Blair William & Co. IL Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Blair William & Co. IL trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 369,909 shares of the healthcare conglomerate's stock after selling 22,845 shares during the quarter. Blair William & Co. IL's holdings in UnitedHealth Group were worth $187,122,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Howard Capital Management Group LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $341,000. Principal Financial Group Inc. boosted its holdings in shares of UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after buying an additional 180,479 shares in the last quarter. Algert Global LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $1,763,000. Cadence Bank grew its holdings in UnitedHealth Group by 1.7% in the third quarter. Cadence Bank now owns 2,794 shares of the healthcare conglomerate's stock worth $1,634,000 after purchasing an additional 46 shares during the period. Finally, Baldwin Investment Management LLC boosted its position in shares of UnitedHealth Group by 2.7% during the 3rd quarter. Baldwin Investment Management LLC now owns 2,800 shares of the healthcare conglomerate's stock worth $1,637,000 after purchasing an additional 74 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on UNH shares. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday, January 17th. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a report on Tuesday, December 3rd. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Finally, Oppenheimer boosted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $629.32.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH traded down $0.25 during trading hours on Friday, hitting $515.47. The company's stock had a trading volume of 2,378,211 shares, compared to its average volume of 4,268,981. The company has a market cap of $471.51 billion, a price-to-earnings ratio of 33.26, a PEG ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business has a 50 day simple moving average of $508.81 and a two-hundred day simple moving average of $544.24. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.83 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.